Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma... Show more
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ATEC advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on ATEC as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ATEC just turned positive on April 14, 2025. Looking at past instances where ATEC's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
ATEC moved above its 50-day moving average on April 17, 2025 date and that indicates a change from a downward trend to an upward trend.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATEC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ATEC broke above its upper Bollinger Band on April 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ATEC entered a downward trend on April 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATEC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (24.631) is normal, around the industry mean (23.728). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.508) is also within normal values, averaging (41.794).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a holding company with interests in medical equipment and supplies
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BCIIX | 16.64 | 0.12 | +0.73% |
Brown Capital Mgmt Intl All Com Inv | |||
NAPIX | 62.46 | N/A | N/A |
Voya Multi-Manager International Sm Cp I | |||
RNGCX | 52.09 | N/A | N/A |
American Funds New Economy R3 | |||
TOLLX | 16.71 | N/A | N/A |
DWS RREEF Global Infrastructure A | |||
RSESX | 14.75 | N/A | N/A |
Russell Inv US Strategic Equity S |
A.I.dvisor indicates that over the last year, ATEC has been loosely correlated with LAB. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ATEC jumps, then LAB could also see price increases.
Ticker / NAME | Correlation To ATEC | 1D Price Change % | ||
---|---|---|---|---|
ATEC | 100% | +3.42% | ||
LAB - ATEC | 45% Loosely correlated | -3.15% | ||
GMED - ATEC | 45% Loosely correlated | +2.47% | ||
TMCI - ATEC | 42% Loosely correlated | +2.40% | ||
TFX - ATEC | 36% Loosely correlated | +1.20% | ||
MYGN - ATEC | 33% Loosely correlated | -1.88% | ||
More |